NO961478L - Levobupivacaine anvendelig for kontroll av kronisk smerte - Google Patents

Levobupivacaine anvendelig for kontroll av kronisk smerte

Info

Publication number
NO961478L
NO961478L NO961478A NO961478A NO961478L NO 961478 L NO961478 L NO 961478L NO 961478 A NO961478 A NO 961478A NO 961478 A NO961478 A NO 961478A NO 961478 L NO961478 L NO 961478L
Authority
NO
Norway
Prior art keywords
levobupivacaine
pct
chronic pain
useful
sec
Prior art date
Application number
NO961478A
Other languages
English (en)
Other versions
NO961478D0 (no
NO309304B1 (no
Inventor
Hazel Judith Bardsley
Laurence Mather
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10743430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO961478(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of NO961478D0 publication Critical patent/NO961478D0/no
Publication of NO961478L publication Critical patent/NO961478L/no
Publication of NO309304B1 publication Critical patent/NO309304B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
NO961478A 1993-10-13 1996-04-12 Anvendelse av levobupivacain for kontroll av kronisk smerte NO309304B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321061A GB9321061D0 (en) 1993-10-13 1993-10-13 Analgestic agent and its use
PCT/GB1994/002248 WO1995010276A1 (en) 1993-10-13 1994-10-13 Levobupivacaine useful for managing chronic pain

Publications (3)

Publication Number Publication Date
NO961478D0 NO961478D0 (no) 1996-04-12
NO961478L true NO961478L (no) 1996-06-11
NO309304B1 NO309304B1 (no) 2001-01-15

Family

ID=10743430

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961478A NO309304B1 (no) 1993-10-13 1996-04-12 Anvendelse av levobupivacain for kontroll av kronisk smerte

Country Status (16)

Country Link
US (1) US5955479A (no)
EP (1) EP0723444B1 (no)
JP (1) JPH09503777A (no)
KR (1) KR100343314B1 (no)
CN (1) CN1074919C (no)
AT (1) ATE154758T1 (no)
AU (1) AU692477B2 (no)
CA (1) CA2173208C (no)
DE (1) DE69403969T2 (no)
DK (1) DK0723444T3 (no)
ES (1) ES2105766T3 (no)
GB (1) GB9321061D0 (no)
GR (1) GR3024787T3 (no)
HK (1) HK1006421A1 (no)
NO (1) NO309304B1 (no)
WO (1) WO1995010276A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU224226B1 (hu) * 1995-04-13 2005-06-28 Darwin Discovery Limited Levobupivacaine alkalmazása terhesség esetén használható érzéstelenítő hatású gyógyszerkészítmény előállítására
GB9704370D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704352D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
JP4521117B2 (ja) * 1997-07-21 2010-08-11 ブルース・エイチ・レヴィン 偏頭痛、群発性頭痛、緊張性頭痛、血管疾患に伴う頭痛、耳鳴りまたは筋肉性頭痛を治療するための医薬
EP0998287B1 (en) * 1997-07-22 2003-05-07 Darwin Discovery Limited Use of levobupivacaine
PT1014946E (pt) 1997-09-18 2010-07-06 Pacira Pharmaceuticals Inc COMPOSIÎES ANESTéSICAS LIPOSSOMAIS DE LIBERTAÆO SUSTENTADA
EP1030652B1 (en) 1997-11-14 2012-04-25 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
HU228143B1 (en) * 1997-11-19 2012-12-28 Darwin Discovery Ltd Anaesthetic formulation
ES2325141T3 (es) 1998-07-17 2009-08-26 Pacira Pharmaceuticals, Inc. Composiciones biodegradables para la liberacion controlada de sustancias encapsuladas.
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
AU2002322024B2 (en) * 2001-05-31 2008-05-08 Pacira Pharmaceuticals, Inc. Encapsulation of nanosuspensions in liposomes and microspheres
DE60239556D1 (de) 2001-11-14 2011-05-05 Durect Corp Katheterinjizierbare depotzusammensetzungen und deren verwendung
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
MXPA05001244A (es) 2002-07-31 2005-06-08 Alza Corp Composiciones de deposito de polimero multimodal inyectable y usos de las mismas.
AU2002359397B2 (en) 2002-07-31 2009-01-29 Durect Corporation Injectable depot compositions and uses thereof
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
DE102008037682A1 (de) * 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
JP2020503324A (ja) * 2016-12-26 2020-01-30 セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ 慢性疼痛の処置のための組成物及び方法
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
WO2023215604A1 (en) 2022-05-05 2023-11-09 Pfof Llc Anesthetic nerve block and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
JPH09503778A (ja) * 1993-10-13 1997-04-15 カイロサイエンス・リミテッド 鎮痛剤およびその使用
ITTO20010597A1 (it) * 2001-06-20 2002-12-20 Plaset Spa Pompa per liquidi, in particolare pompa centrifuga per apparecchi elettrodomestici.

Also Published As

Publication number Publication date
EP0723444B1 (en) 1997-06-25
ATE154758T1 (de) 1997-07-15
CN1074919C (zh) 2001-11-21
CA2173208A1 (en) 1995-04-20
DE69403969T2 (de) 1997-11-20
CA2173208C (en) 2007-01-30
AU7859394A (en) 1995-05-04
EP0723444A1 (en) 1996-07-31
GB9321061D0 (en) 1993-12-01
WO1995010276A1 (en) 1995-04-20
HK1006421A1 (en) 1999-02-26
ES2105766T3 (es) 1997-10-16
DK0723444T3 (da) 1997-12-29
JPH09503777A (ja) 1997-04-15
KR100343314B1 (ko) 2003-02-19
DE69403969D1 (de) 1997-07-31
NO961478D0 (no) 1996-04-12
NO309304B1 (no) 2001-01-15
US5955479A (en) 1999-09-21
GR3024787T3 (en) 1998-01-30
CN1133009A (zh) 1996-10-09
AU692477B2 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
NO961478D0 (no) Levobupivacaine anvendelig for kontroll av kronisk smerte
DE69533040D1 (de) Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
HU9301978D0 (en) Application of complementary inhibitors in medical preparatives used for treatment of inflammatory diseases of intestines and skin
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
IL130083A0 (en) 3-Pyridyl enantiomers and their use as analgesics
NO943049L (no) Anvendelse av 4-aminopyridin ved behandling av en nevrologisk tilstand
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE69924979D1 (de) Behandlung von chronischen schmerzen
ATE236630T1 (de) Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
DE69307702T2 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
GR3032531T3 (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
ATE150645T1 (de) Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин
UA39559A (uk) Спосіб лікування кандидозного вульвовагініту

Legal Events

Date Code Title Description
MK1K Patent expired